Table 4 Other measures of treatment outcomes in children ≤ 2 treated with artesunate-amodiaquine or artemether-lumefantrine

Parasite prevalence on day 1

126

58

68

0.62

Parasite positivity rate on day 3

3

2

1

0.61

 Geometric mean

5.5 × 10²

5.6 × 10²

5.4 × 10²

0.79

 Range

1.1 × 10⁻¹–2.9 × 10⁵

1.1 × 10⁻¹–1.3 × 10⁵

4.1 × 10⁻¹–2.9 × 10⁵

 Geometric mean

1.1 × 10⁴

1.0 × 10⁴

1.1 × 10⁴

0.7

 Range

1.9 × 10¹–3.0 × 10⁵

1.9 × 10¹–1.3 × 10⁵

2.6 × 10¹–3.0 × 10⁵

 Mean

1.3

1.3

1.4

0.83

 95 % CI

1.2–1.5

1.1–1.5

1.1–1.6

 Mean

1.6

1.5

1.6

0.46

 95 % CI

1.5–1.7

1.4–1.7

1.5–1.7